Study Guide to Substance Abuse Treatment is a question-and-answer companion that allows you to evaluate your mastery of the subject matter as you progress through The American Psychiatric Publishing Textbook of Substance Abuse Treatment, Fifth Edition. The Study Guide is made up of questions divided into individual quizzes of 10-20 questions each that correspond to the chapters in the Textbook. Questions are followed by an Answer Guide that references relevant text (including the page number) in the Textbook to allow quick access to needed information. Each answer is accompanied by a discussion that addresses the correct response and also (when appropriate) explains why other responses are not correct.
Philip R. Muskin, M.D., is Professor of Psychiatry at Columbia University Medical Center; Chief of Consultation-Liaison Psychiatry at New York--Presbyterian Hospital/Columbia Campus; and on the faculty of the Columbia University Center for Psychoanalytic Training and Research in New York, New York.
ContributorsPrefacePart I: QuestionsChapter 1. Neurobiology of AddictionChapter 2. Genetics of AddictionChapter 3. Epidemiology of AddictionChapter 4. Cross-Cultural Aspects of AddictionChapter 5. Science in the Treatment of Substance AbuseChapter 6. Assessment of the PatientChapter 7. Screening and Brief InterventionChapter 8. Patient Placement CriteriaChapter 9. "Recovery" in Chronic Care Disease Management: "Disease Control" in Substance Use DisordersChapter 10. Neurobiology of Alcohol Use DisorderChapter 11. Treatment of Alcohol Intoxication and Alcohol WithdrawalChapter 12. Neurobiology of StimulantsChapter 13. Clinical Management: CocaineChapter 14. Clinical Management: MethamphetamineChapter 15. Hallucinogens and Club DrugsChapter 16. Tobacco Use DisorderChapter 17. Benzodiazepines and Other Sedatives and HypnoticsChapter 18. Treatment of Anabolic-Androgenic Steroid--Related DisordersChapter 19. Neurobiology of Opiates and OpioidsChapter 20. Opioid DetoxificationChapter 21. Methadone and Buprenorphine MaintenanceChapter 22. Opioid AntagonistsChapter 23. Neurobiology of MarijuanaChapter 24. Treatment of Cannabis Use DisorderChapter 25. Psychodynamic PsychotherapyChapter 26. Cognitive-Behavioral TherapiesChapter 27. Motivational EnhancementChapter 28. Twelve-Step Facilitation: An Adaptation for Psychiatric Practitioners and PatientsChapter 29. Contingency ManagementChapter 30. Network TherapyChapter 31. Group TherapyChapter 32. Family TherapyChapter 33. Inpatient TreatmentChapter 34. Therapeutic CommunitiesChapter 35. Community-Based TreatmentChapter 36. History of Alcoholics Anonymous and the Experiences of PatientsChapter 37. Psychological Mechanisms in Alcoholics AnonymousChapter 38. Outcomes Research on Twelve-Step ProgramsChapter 39. Women and AddictionChapter 40. Perinatal Substance Use DisordersChapter 41. Adolescent Substance Use Disorders: Epidemiology, Neurobiology, and ScreeningChapter 42. Adolescent Substance Use Disorders: Transition to Substance Abuse, Prevention, and TreatmentChapter 43. Psychiatric Consultation in Pain and AddictionChapter 44. Prevention of Prescription Drug AbuseChapter 45. HIV/AIDS and Hepatitis CChapter 46. Substance Use Disorders Among PhysiciansChapter 47. Substance Use Issues Among Lesbian, Gay, Bisexual, and Transgender PeopleChapter 48. MinoritiesChapter 49. Testing to Identify Recent Drug AbuseChapter 50. Medical Education on AddictionChapter 51. Prevention of Substance AbuseChapter 52. Forensic Addiction PsychiatryChapter 53. Substance Abuse and Mental Illness